Filippo G De Braud

16PUBLICATIONS
188CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsContext learningCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 08, 2026
First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies.

|Jun 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

|May 04, 2026
CAR-engineering of innate and innate-like immune cells: a new horizon in adoptive cell therapy for solid tumors.

|Nov 24, 2025
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.

Federica Corso, Vittoria Peppoloni, Laura Mazzeo

|May 07, 2025
Effect of immuno-oncology on clinical and economic outcomes for a selection of cancers in Italy.

Beatrice Canali, Giovanni Apolone, Paolo A Ascierto

|Mar 05, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma.

Sumanta K Pal, Alice Bernard-Tessier, Peter Grell

Pageof 3

Frequent Collaborators

3 joint publications

Sara Lonardi

3 joint publications

Filippo Pietrantonio

3 joint publications

Federica Morano

2 joint publications

Alessia Mennitto